Search

California Seizes Over $1.2 Billion in Illegal Cannabis

California announced state officers have seized and destroyed over $1.2 billion in illicit cannabis products through the Unified Cannabis Enforcement Task Force (UCETF). Seizures in 2025 alone reached $609 million, an 18-fold increase since 2022, highlighting the state's efforts to combat the illegal market.

I&S LLC Stipulation, Agreement, and Order

The Federal Trade Commission (FTC) has entered into a Stipulation, Agreement, and Order with I&S LLC. The order addresses alleged deceptive advertising practices related to the company's subscription services. I&S LLC has agreed to specific terms to resolve these allegations.

Dutch Botanicals LLC Stipulation Agreement Order

The US Food and Drug Administration (FDA) has issued a Stipulation Agreement Order against Dutch Botanicals LLC. This order likely addresses violations related to the manufacturing or marketing of food products, requiring specific actions and potentially imposing penalties.

Galactic Meds LLC Stipulation, Agreement, and Order

The US Department of Justice has entered into a Stipulation, Agreement, and Order with Galactic Meds LLC. This agreement resolves alleged violations related to the False Claims Act, requiring Galactic Meds LLC to pay a settlement amount and implement compliance measures.

Grateful Grove LLC Stipulation Agreement Order

The Federal Trade Commission (FTC) issued a Stipulation Agreement Order against Grateful Grove LLC for deceptive advertising practices related to its "Get Sleep" product. The order prohibits the company from making unsubstantiated claims about the product's efficacy and requires specific disclosures.

Medical Board of California: SB 815 Changes

California's SB 815, effective January 1, 2024, enacts significant changes to the Medical Board of California, including increased physician licensing and renewal fees, extended Postgraduate Training License validity, and expanded guest rotation training allowances. The bill also establishes a Complainant Liaison Unit to improve communication regarding the enforcement process.

Medical Board of California Elects 2024-2025 Leadership

The Medical Board of California has announced its elected leadership for the 2024-2025 term, with Kristina D. Lawson continuing as President. The board also highlighted physician mental health and wellness as a key priority for the upcoming year.

Medical Board of California Annual Report 2023-2024

The Medical Board of California has released its Annual Report for Fiscal Year 2023-2024. The report details the Board's activities, including licensing, enforcement programs, and implementation of legislative changes. It also provides updates on pilot programs and regulatory revisions.

CURES AB 82 Exempts Testosterone and Mifepristone Reporting

California Assembly Bill 82, signed into law on October 13, 2025, exempts dispensers from reporting the dispensing of testosterone and mifepristone to the CURES database. This change impacts dispensers of these specific controlled substances within the state.

Medical Board of California Annual Report 2024-2025

The Medical Board of California has released its Annual Report for Fiscal Year 2024-2025. The report summarizes the Board's activities, including progress on physician wellness programs, budget updates, licensing process improvements, and enforcement statistics.